Citation Impact

Citing Papers

Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
2017 Standout
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Inference and analysis of cell-cell communication using CellChat
2021 Standout
Reconstruction of cell spatial organization from single-cell RNA sequencing data based on ligand-receptor mediated self-assembly
2020
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Identification of del(20q) in a subset of patients diagnosed with idiopathic thrombocytopenic purpura
2008
Effect of Limited DNA Methylation Reprogramming in the Normal Sheep Embryo on Somatic Cell Nuclear Transfer1
2004
Idiopathic thrombocytopenic purpura in elderly patients: A study of 47 cases from a single reference center
2008
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes
2018 StandoutNobel
Nuclear Transfer to Eggs and Oocytes
2011 StandoutNobel
Biology of Natural Killer Cells
1989 Standout
Polychlorinated Biphenyls (PCBs), Dibenzo-p-Dioxins (PCDDs), Dibenzofurans (PCDFs), and Related Compounds: Environmental and Mechanistic Considerations Which Support the Development of Toxic Equivalency Factors (TEFs)
1990 Standout
Treatment challenges in the management of relapsed or refractory non-Hodgkin’s lymphoma – novel and emerging therapies
2013
Regulation of hematopoiesis by T lymphocytes and natural killer cells
1987
Human tumor xenografts as model for drug testing
1988
Immune studies in dioxin-exposed Missouri residents: Quail run
1987
Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL study
2015
Targeted drug delivery for cancer therapy: the other side of antibodies
2012
Cancer-related fatigue—mechanisms, risk factors, and treatments
2014 Standout
Targeting Immunosupportive Cancer Therapies: Accentuate the Positive, Eliminate the Negative
2007 StandoutNobel
The PI3K Pathway in Human Disease
2017 Standout
Lymphoid subsets in acute myeloid leukemias: Increased number of cells with NK phenotype and normal T-cell distribution
1993
Single-Agent Pixantrone as a Bridge to Autologous Stem Cell Transplantation in a Patient with Refractory Diffuse Large B-Cell Lymphoma
2017 Standout
The role of lipid peroxidation and antioxidants in oxidative modification of LDL
1992 Standout
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Long term effects on the immune system following local radiation therapy for breast cancer. I. Cellular composition of the peripheral blood lymphocyte population
1985
Nitric Oxide Suppresses Human T Lymphocyte Proliferation Through IFN-γ-Dependent and IFN-γ-Independent Induction of Apoptosis
1999
Nitric oxide and the immune response
2001 Standout
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Existence of a pool of T-lymphocyte colony-forming cells (T-CFC) in human bone marrow and their place in the differentiation of the T- lymphocyte lineage
1981
Calcitonin gene-related peptide is a potent vasodilator
1985 StandoutNature
KATACALCIN: A NEW PLASMA CALCIUM-LOWERING HORMONE
1983
Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma
2008 StandoutNobel
Expression of NK-lineage markers on peripheral blood lymphocytes with T- helper (Leu3+/T4+) phenotype in B cell chronic lymphocytic leukemia
1985
The emerging role of immune checkpoint based approaches in AML and MDS
2017 StandoutNobel
Buparlisib, a PI3K inhibitor, demonstrates acceptable tolerability and preliminary activity in a phase I trial of patients with advanced leukemias
2016
Responses to Human CD40 Ligand/Human Interleukin-2 Autologous Cell Vaccine in Patients with B-Cell Chronic Lymphocytic Leukemia
2005
Expanded HIV-1 Cellular Tropism by Phenotypic Mixing with Murine Endogenous Retroviruses
1990 Science
Hypoplastic anemia in B cell chronic lymphocytic leukemia: evolution of T cell-mediated suppression of erythropoiesis in early-stage and late- stage disease
1985
Peripheral blood adherent cells from AIDS patients inhibit normal T-colony growth through decreased expression of interleukin 2-receptors and production of interleukin 2
1987 StandoutNobel
Rapid down‐regulation of protein kinase C and membrane association in phorbol ester‐treated leukemia cells
1985
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
2015 Standout
Fatty acid metabolism and cell proliferation: IV. Effect of prostanoid biosynthesis from endogenous fatty acid release with cyclosporin‐A
1983
Rapid microassay for protein kinase C translocation in Swiss 3T3 cells
1986 StandoutNobel
Heterogeneity of peripheral blood T-cell colony-forming cells in patients with T-cell malignancies
1984
T gamma (T gamma) cells suppress growth of erythroid colony-forming units in vitro in the pure red cell aplasia of B-cell chronic lymphocytic leukemia.
1982
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
1996 StandoutScience
Chronic low-dose gamma-radiation exposure and the alteration of the distribution of lymphocyte subpopulations in residents of radioactive buildings
1999
Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models.
2003 Standout
Nitric oxide suppresses human T lymphocyte proliferation through IFN-gamma-dependent and IFN-gamma-independent induction of apoptosis.
1999

Works of Roberto Foà being referenced

The pan-class I phosphatidyl-inositol-3 kinase inhibitor NVP-BKM120 demonstrates anti-leukemic activity in acute myeloid leukemia
2015
Accessory Cells, Cytokine Loops and Cell‐to‐Cell Interactions in Chronic Lymphocytic Leukemia
2000
Results of a phase I/II study of ocrelizumab, a fully humanized anti-CD20 mAb, in patients with relapsed/refractory follicular lymphoma
2010
High-Dose Therapy and Autologous Stem Cell Transplantation in First Relapse for Diffuse Large B Cell Lymphoma in the Rituximab Era: An Analysis Based on Data from the European Blood and Marrow Transplantation Registry
2011
Idiopathic thrombocytopenic purpura (ITP) in the elderly: clinical course in 178 patients
2006
Defective lymphokine-activated killer cell generation and activity in acute leukemia patients with active disease
1991
Increase in Tγ Lymphocytes in B‐Cell Chronic Lymphocytic Leukaemia
1980
Production of immunoreactive calcitonin by myeloid leukaemia cells
1982
Increased proportion of suppressor/cytotoxic (OKT8+) cells in patients with Hodgkin's disease in long-lasting remission
1983
Increase in Ty Lymphocytes in B‐Cell Chronic Lymphocytic Leukaemia
1981
REDUCED T‐COLONY FORMING CAPACITY BY T‐LYMPHOCYTES FROM B‐CHRONIC LYMPHOCYTIC LEUKAEMIA
1980
Lineage relationship of chronic lymphocytic leukemia and hairy cell leukemia: Studies with TPA
1984
Serial Transplantation of a Human Acute T Lymphoblastic Leukemia into Nude Mice
1986
Inhibitory effect of cyclosporin A on peripheral blood and bone marrow T lymphocyte colony formation.
1981
Methylation levels of normal and chronic lymphocytic leukemia B lymphocytes: computer-assisted quantitative analysis of anti-5-methylcytosine antibody binding to individual nuclei
1999
T lymphocytes in B-cell chronic lymphocytic leukemia: Characterization by monoclonal antibodies and correlation with Fc receptors
1983
T-lymphocyte colonies in normal blood, bone marrow and lymphoproliferative disorders.
1979
Rankless by CCL
2026